A network analysis model was employed to identify the central symptoms and associated influencing factors among patients with gastric cancer undergoing chemotherapy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300076199

Enrollment

Unknown

Registered

2023-09-27

Start date

2023-10-01

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Group of primary gastric cancer:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Pathological diagnosis of primary gastric cancer; ? Patients with gastric cancer receiving intravenous chemotherapy or intravenous chemotherapy combined with other treatments; ? Age 18-75 years old, able to communicate with language, KPS evaluation ?60 points; ?Patients clearly identify their own illness and agree to participate.

Exclusion criteria

Exclusion criteria: ? Patients with severe cognitive dysfunction or mental illness; ? Patients with severe heart, brain, kidney and other dysfunction.

Design outcomes

Primary

Measure	Time frame
The Chinese Version of M.D. anderson Symptom Inventory, MDASI-C;Fear of progression;General Self Efficacy Scale,GSES;CD-RISC;	—

Countries

China

Contacts

Public ContactZou yanling

Jiangsu Provincial Hospital of Traditional Chinese Medicine

1097332508@qq.com+86 183 6297 9857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026